Carcinoma, Non-Small-Cell Lung

• Pfizer Investigational Site — Birmingham, Alabama, United States
• Pfizer Investigational Site — Birmingham, Alabama, United States
• Pfizer Investigational Site — Birmingham, Alabama, United States
• Pfizer Investigational Site — Nashville, Tennessee, United States

• University General Hospital of Alexandroupolis, Dep of Medical Oncology — Alexandroupoli, Greece
• " General Hospital, 1st, 3rd, 8th Dep of Pulmonary Diseases — Athens, Greece
• "Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine — Athens, Greece
• "Metaxa's" Anticancer Hospital of Piraeus,1st Dep of Medical Oncology — Athens, Greece

• University General Hospital of Alexandroupolis, Department of Medical Oncology — Alexandroupoli, Greece
• 401 Military Hospital of Athens — Athens, Greece
• Air Forces Military Hospital of Athens — Athens, Greece
• IASO General Hospital of Athens, 1st Department of Medical Oncology — Athens, Greece

• Pfizer Investigational Site — Baltimore, Maryland, United States
• Pfizer Investigational Site — City of Saint Peters, Missouri, United States
• Pfizer Investigational Site — St Louis, Missouri, United States
• Pfizer Investigational Site — St Louis, Missouri, United States

Not specified

• Veeda Oncology — Houston, Texas, United States

• Fountain Valley, California, United States
• Los Angeles, California, United States
• Palm Springs, California, United States
• Columbia, Missouri, United States

• Department of Oncology, National Taiwan University Hospital — Taipei, Taiwan

• British Columbia Cancer Agency — Vancouver, British Columbia, Canada

Not specified